Quidel has secured FDA clearance for the Molecular Influenza A+B test, which is used to spot influenza A and/or B virus as well as H3N2v, and the Molecular RSV+hMPV test, which is used to diagnose respiratory syncytial virus and/or human metapneumovirus. The two assays are cleared for use on the QuantStudio Dx Real-Time PCR instrument developed by Life Technologies.

Related Summaries